sarepta fda elevidys - Search News

Order byBest matchMost fresh

News

FDA Will Ask Sarepta to Halt Gene Therapy Shipments

Sarepta's Shocking Stand: Company Rejects FDA Request To Pull Gene Therapy Elevidys

FDA places clinical hold on Sarepta's LGMD gene therapy trials after three deaths and revokes platform tech designation due to safety concerns.

Continue reading

· 2d · on MSN

Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys

Sarepta Stands Ground Against HHS Request to Stop Elevidys Shipments

3hon MSN

Sarepta extends losses premarket after refusing FDA’s halt request

Sarepta Therapeutics (SRPT) shares fell as much as 4.8% in premarket trading Monday, poised to extend losses for a second ...

40m

Sarepta Therapeutics: Why Is SRPT Stock Crashing?

The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.

10hon MSN

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results